# Inflammation-mediated facial nodules to compounded tirzepatide.

> PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42598502-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-08-14
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42598502-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42598502-tirzepatide-v1.json
- Content SHA-256: `249b1cf4ebb49b074c3399bd5846046ca184f1b62da401b88bafaaac5443b16f`

## Claims and source pins

### Headline

Inflammation-mediated facial nodules to compounded tirzepatide. ([`pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5`](#source-pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5))

### Summary

PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5`](#source-pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5))

### Paragraph 1

PubMed lists PMID 42598502 in JAAD case reports as Letter, with publication-date metadata of 2026-06-17 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5`](#source-pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5`](#source-pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5))

## Sources

<a id="source-pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5"></a>
- **Inflammation-mediated facial nodules to compounded tirzepatide. · retained source version 1:2026-08-14:current:2b079cc362b53630676caa02a1de041a7ab692c920125f3584f0ab06b4c3b041** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42598502/) (`pubmed-observation-pmid-42598502-2026-08-14-2b079cc362b5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Inflammation-mediated facial nodules to compounded tirzepatide." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42598502-tirzepatide-v1.json SHA-256: 249b1cf4ebb49b074c3399bd5846046ca184f1b62da401b88bafaaac5443b16f.